After Much Delay, US FDA Releases CMO Quality Agreements

Currently, under cGMP regulations pharmaceutical companies are not required to have written quality agreements, but the FDA is suggesting companies adopt such agreements as a preventative measure. These agreements are suggested to include a puropse/scope, effective and termination dates, dispute resolution, responsibilities, change control and revisions. Read the full story.